Global GMP Cell Culture Custom Service Supply, Demand and Key Producers, 2026-2032

November 2026 | 230 pages | ID: G21FEB5601C0EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global GMP Cell Culture Custom Service market size is expected to reach $ 7598 million by 2032, rising at a market growth of 5.8% CAGR during the forecast period (2026-2032).

GMP cell culture custom service is a type of professional contract service provided by CDMOs, CMOs, biopharmaceutical manufacturing platforms, and cell therapy manufacturing organizations. It is tailored to the product, cell line, clinical stage, and quality system requirements of pharmaceutical and biotechnology clients. Services include cell line establishment and screening, master cell bank and working cell bank establishment, culture condition and medium adaptation, upstream cell culture process development, process optimization, scale-up, and technology transfer, as well as cell culture, expansion, and clinical or commercial manufacturing that meets GMP/cGMP requirements.

Key Findings

Mammalian cells and immune cells constitute the two cell-type categories of GMP Cell Culture Custom Service

Single-batch culture scale is segmented into ≤10 L and ≥10 L

Adherent and suspension processes represent the two core culture-system configurations

Process reproducibility scale-up and GMP technology transfer are central commercial capabilities

Gene therapy biopharmaceuticals and vaccine programs form the principal application groups

Market Trends

GMP Cell Culture Custom Service is shifting toward integrated development-to-manufacturing platforms that connect cell-line or starting-cell preparation, upstream process development, analytical support, scale-up, technology transfer and GMP production within a unified quality framework. In mammalian-cell manufacturing, suspension culture remains a major route for scalable biologics production, supported by fed-batch, intensified and perfusion processes, while single-use bioreactors are increasing flexibility across clinical and commercial stages. WuXi Biologics has demonstrated suspension-adapted HEK293 platforms scalable to 1,000 L perfusion and 2,000 L fed-batch manufacturing, while Samsung Biologics and Lonza operate cGMP mammalian production at substantially larger commercial scales. Adherent culture remains relevant for selected viral-vector, vaccine and other cell-dependent processes, and suppliers are increasingly developing pathways to migrate appropriate processes toward scalable suspension or intensified configurations. Immune-cell programs are following a parallel path toward closed processing, automation, standardized expansion and stronger control of cell identity and viability. The long-term direction is therefore toward flexible platforms capable of supporting both ≤10 L development or specialized batches and ≥10 L clinical and commercial manufacturing with consistent analytical and quality control.

Market Dynamics

Drivers

The principal driver of GMP Cell Culture Custom Service is the expanding technical complexity of biologics, gene therapy, vaccine and cell-based development programs. Mammalian cells are widely used to produce antibodies, recombinant proteins and other structurally complex biologics, while HEK293 and related cell systems are important in viral-vector and vaccine development. Immune-cell programs require specialized expansion and handling capabilities that many developers do not maintain internally. Outsourcing gives customers access to qualified cleanroom infrastructure, experienced process-development teams, analytical laboratories, validated quality systems and GMP manufacturing without establishing equivalent facilities themselves. Another important driver is the transition from development scale to regulated production. Cell growth, productivity, product quality and viability must remain controlled as processes move from laboratory vessels into larger bioreactors or manufacturing suites, making scale-up expertise and technology-transfer discipline commercially important. Leading providers increasingly connect cell-line development, process development, analytical testing and GMP production to reduce handoffs and preserve process knowledge across development stages.

Restraints

Market development is constrained by biological variability, demanding GMP requirements and the difficulty of transferring cell-culture processes across equipment scales. Cell performance can change with media composition, passage history, oxygen transfer, shear stress, mixing, temperature and nutrient gradients, so a process established at small scale may require substantial optimization before larger-scale manufacturing. Adherent systems can become operationally complex as required culture surface area increases, while suspension systems demand robust bioreactor control and reproducible high-density growth. Immune-cell programs create additional variability because starting materials and critical cell attributes can differ between batches. GMP execution also requires qualified facilities, environmental monitoring, trained operators, analytical release testing, data integrity and extensive documentation. Specialized production suites therefore carry significant fixed costs, while early-stage customer programs may have uncertain schedules or changing batch requirements. These factors can constrain capacity utilization and make flexible manufacturing design an important economic consideration.

Opportunities

The strongest opportunities lie in scalable suspension culture, intensified processing, flexible single-use systems, immune-cell manufacturing and integrated gene-therapy workflows. For mammalian programs, improvements in cell-line productivity, high-cell-density culture, perfusion and single-use bioreactors can raise output while allowing capacity to be adjusted more flexibly between clinical and commercial campaigns. AGC Biologics uses single-use mammalian systems across a range of production scales, while WuXi Biologics has developed both adherent and suspension processes for viral vaccines and scalable HEK293 platforms for difficult-to-express molecules. Gene-therapy programs create further opportunities because cell cultivation can be integrated with plasmid, AAV, lentiviral-vector and downstream processing services. ProBio operates both adherent and suspension GMP lentiviral-vector processes, demonstrating how culture-system flexibility can support different development stages. Immune-cell manufacturing provides another specialized opportunity where controlled expansion, closed processing and multi-suite GMP operations are important. Providers that can support ≤10 L development and specialized batches while retaining a pathway into ≥10 L production can capture a larger portion of the customer lifecycle.

Challenges

The main long-term challenge is maintaining biological and process consistency as products move between scales, sites and development stages. Changes in vessel geometry, mixing, oxygen transfer and cell density can influence growth kinetics and product characteristics, requiring scientifically justified scale-up and comparability strategies. Immune-cell production adds further complexity because identity, phenotype, viability and potency must be preserved while starting material may vary. Service providers also need to accommodate different customer cell lines, media, vectors, analytical methods and release specifications without compromising cross-contamination controls or quality-system consistency. Capacity planning is another challenge: commercial mammalian biologics can favor larger production assets, whereas early gene-therapy, vaccine and immune-cell programs may require smaller and more flexible suites. The ability to balance equipment utilization, rapid scheduling, trained personnel and validated processes therefore has a direct effect on service economics. As customers increasingly expect end-to-end support, providers must also manage technology transfer, analytical comparability, digital records and regulatory documentation across multiple functional teams and sites.

Industry Chain Analysis

The upstream industry chain of GMP Cell Culture Custom Service includes production cell lines and starting biological materials, master and working cell banks, culture media, feeds, cytokines and growth factors, single-use assemblies, bioreactors, cell-retention systems, microcarriers or fixed-bed equipment for selected adherent processes, filtration systems, sensors, process analytical technologies and supporting laboratory instruments. Mammalian-cell manufacturing commonly uses CHO and HEK-derived systems, while immune-cell programs require specialized activation, expansion and preservation inputs. Culture-system selection materially affects equipment architecture: suspension cells can generally be scaled through stirred bioreactors, while adherent cells require suitable surfaces, microcarriers, fixed-bed systems or related configurations. Single-use equipment is increasingly used because it can reduce changeover requirements and provide flexibility across multiple products, while large commercial biologics programs may also employ high-capacity stainless-steel assets.

The midstream creates value through process design, cell banking, culture optimization, scale-up, technology transfer, GMP cultivation, in-process testing, harvest, analytical development, quality control and regulatory documentation. Downstream applications include gene therapy, biopharmaceuticals, vaccine R&D and production, and other cell-dependent products. Commercial value is highest when the provider can maintain continuity from development into regulated manufacturing while preserving critical process parameters and product-quality attributes. Integrated service platforms can further connect cell culture with downstream purification, viral-vector manufacturing, analytical testing and fill-finish, reducing technical handoffs between organizations. Cost and margin structures are influenced by cleanroom utilization, bioreactor capacity, single-use consumables, media, quality-control testing, specialized personnel and project scheduling. Consequently, manufacturing flexibility and utilization management are central to service economics.

Segment Insights

By cell type, mammalian-cell GMP Cell Culture Custom Service supports a broad range of antibodies, recombinant proteins, viral products and other biologics, with commercial performance dependent on cell-line stability, productivity, product-quality attributes and scalable bioreactor operation. The segment spans small process-development systems through very large commercial manufacturing assets, giving it a broad scale profile. Immune-cell services follow a different production logic because the cultured cells themselves may represent a critical therapeutic component, placing greater emphasis on identity, phenotype, viability, controlled expansion and closed processing. GC Cell’s capabilities across NK, T and stem-cell modalities illustrate the specialized process-development and manufacturing requirements associated with this category.

By single-batch culture scale, ≤10 L projects are more closely associated with process development, early-stage material generation, immune-cell expansion, optimization studies and other applications that prioritize flexibility over volume. ≥10 L manufacturing becomes increasingly important when programs progress into clinical supply, viral-vector production and commercial biologics, where scale-up reproducibility, manufacturing utilization and batch economics carry greater weight. By culture system, suspension processing provides a direct pathway toward stirred-tank scale-up and is widely used for mammalian production, while adherent culture remains technically important for selected viral-vector and vaccine processes. Official commercial platforms demonstrate that both approaches continue to coexist, with several providers offering adherent and suspension options according to the biology and development stage of the customer program.

Downstream Market Opportunities

Biopharmaceuticals provide a broad application base for GMP Cell Culture Custom Service because mammalian-cell platforms support antibodies, recombinant proteins, fusion proteins and other complex biologics requiring clinical and commercial production. Gene therapy expands demand through producer-cell cultivation and viral-vector manufacturing, with both adherent and suspension HEK293-derived processes used according to vector and scale requirements. Vaccine R&D and production create additional demand for adaptable cell substrates, batch, fed-batch, perfusion and adherent culture configurations. Across these applications, customers increasingly value providers capable of retaining programs from early development through GMP manufacturing because fewer transfers can reduce process re-establishment and comparability risk. The most attractive opportunities are therefore concentrated in integrated platforms that combine cell culture with analytical testing, quality management, viral-vector or downstream capabilities and a clear scale-up pathway from ≤10 L development work into ≥10 L manufacturing.

Regional Insights

North America and Europe have mature biopharmaceutical outsourcing ecosystems with extensive process-development, mammalian-cell manufacturing and advanced-therapy infrastructure. North American facilities support both flexible development programs and large-scale commercial biologics manufacturing; Lonza’s Vacaville site, for example, operates 12,000 L and 25,000 L mammalian bioreactors for late-stage and commercial supply. Europe combines established biologics manufacturing with specialist viral-vector and cell-related capabilities, creating a diversified service base across conventional biologics and advanced modalities. These regions place substantial emphasis on regulatory track record, technology-transfer reliability and integrated analytical and quality support.

Asia has developed a broad and increasingly sophisticated GMP cell-culture service base. Samsung Biologics and WuXi Biologics operate scalable mammalian manufacturing networks, while South Korea also has specialized immune-cell capabilities through GC Cell. Japan is expanding mammalian and advanced-therapy capacity through participants such as AGC, whose Yokohama development includes mammalian and cell-therapy capabilities. China also has a growing group of domestic CDMO providers covering biologics and gene-therapy-related manufacturing. Regional differentiation increasingly depends on flexible scale, single-use technology, local regulatory execution, supply-chain resilience and the ability to support both development-stage and commercial programs. No validated evidence in the current research base supports assigning a single region as the largest or fastest-growing market.

Competitive Landscape Analysis

The competitive landscape of GMP Cell Culture Custom Service combines large integrated biologics CDMOs, advanced-therapy specialists and regional development-and-manufacturing providers. Samsung Biologics competes through large-scale cGMP mammalian cell-culture capacity and clinical-to-commercial drug-substance manufacturing, while WuXi Biologics combines mammalian cell-line development, process development, analytical capabilities and scalable manufacturing. Lonza provides development-to-commercial mammalian manufacturing and cell-bank capabilities, and FUJIFILM, Boehringer Ingelheim, Thermo Fisher Scientific, AGC and other confirmed companies participate through established biopharmaceutical or advanced-therapy CDMO infrastructure. Specialist providers differentiate through narrower modalities and culture expertise: ProBio supports adherent and suspension GMP lentiviral-vector production, while GC Cell focuses on immune-cell and cell-and-gene-therapy manufacturing. Competitive differentiation centers on cell-line and process expertise, adherent and suspension capability, available batch scale, GMP capacity, analytical depth, technology-transfer reliability, regulatory execution, project scheduling and the ability to keep a program within one quality and manufacturing network from development through clinical or commercial supply.

Report Scope

This report studies the global GMP Cell Culture Custom Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for GMP Cell Culture Custom Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GMP Cell Culture Custom Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

  • Global GMP Cell Culture Custom Service total market, 2021-2032, (USD Million)
  • Global GMP Cell Culture Custom Service total market by region & country, CAGR, 2021-2032, (USD Million)
  • U.S. VS China: GMP Cell Culture Custom Service total market, key domestic companies, and share, (USD Million)
  • Global GMP Cell Culture Custom Service revenue by player, revenue and market share 2021-2026, (USD Million)
  • Global GMP Cell Culture Custom Service total market by Type, CAGR, 2021-2032, (USD Million)
  • Global GMP Cell Culture Custom Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global GMP Cell Culture Custom Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Samsung Biologics Co., Ltd., WuXi Biologics (Cayman) Inc., Lonza Group Ltd, Thermo Fisher Scientific Inc. (Patheon), FUJIFILM Holdings Corporation, Boehringer Ingelheim, AGC Inc., Catalent, Inc., KBI Biopharma, Inc., Rentschler Biopharma SE, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world GMP Cell Culture Custom Service market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global GMP Cell Culture Custom Service Market, By Region:

  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World

Market Segmentation

Global GMP Cell Culture Custom Service Market, Segmentation by Type:

  • Mammalian Cells
  • Immune Cells

Global GMP Cell Culture Custom Service Market, Segmentation by Batch Culture Scale:

  • ≤10L
  • ≥10L

Global GMP Cell Culture Custom Service Market, Segmentation by Culture System:

  • Adherent Cells
  • Suspension Cells

Global GMP Cell Culture Custom Service Market, Segmentation by Application:

  • Gene Therapy
  • Biopharmaceuticals
  • Vaccine R&D and Production
  • Other

Companies Profiled:

  • Samsung Biologics Co., Ltd.
  • WuXi Biologics (Cayman) Inc.
  • Lonza Group Ltd
  • Thermo Fisher Scientific Inc. (Patheon)
  • FUJIFILM Holdings Corporation
  • Boehringer Ingelheim
  • AGC Inc.
  • Catalent, Inc.
  • KBI Biopharma, Inc.
  • Rentschler Biopharma SE
  • Curia Global, Inc.
  • Avid Bioservices, Inc.
  • National Resilience, Inc.
  • Abzena plc
  • LOTTE Biologics Co., Ltd.
  • Cytovance Biologics, Inc.
  • BiBo Biopharma Engineering Co., Ltd.
  • Chime Biologics (Wuhan) Co., Ltd.
  • Celonic AG
  • mAbxience
  • Pharmaron Beijing Co., Ltd.
  • GenScript Biotech Corporation (ProBio)
  • GC Cell Corporation
  • SK pharmteco
  • Charles River Laboratories International, Inc.
  • Syngene International Limited
  • Prestige Biologics Co., Ltd.
  • EirGenix, Inc.
  • Shanghai ZhenGe Biotech Co., Ltd.
  • Mycenax Biotech Inc.
  • Bora Pharmaceuticals Co., Ltd. (Bora Biologics)
  • ProBioGen AG
  • OBiO Technology (Shanghai) Corp., Ltd.
  • Enzene Biosciences Ltd.
  • MabPlex International Co., Ltd.
  • Hualan Ankang Shengwu Gufen Youxian Gongsi
  • CHA Biotech Co., Ltd.
  • VIVEbiotech S.L.
  • UNIGEN Inc.
  • Takara Bio Inc.

Key Questions Answered

1. How big is the global GMP Cell Culture Custom Service market?
2. What is the demand of the global GMP Cell Culture Custom Service market?
3. What is the year over year growth of the global GMP Cell Culture Custom Service market?
4. What is the total value of the global GMP Cell Culture Custom Service market?
5. Who are the Major Players in the global GMP Cell Culture Custom Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 GMP Cell Culture Custom Service Introduction
1.2 World GMP Cell Culture Custom Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World GMP Cell Culture Custom Service Total Market by Region (by Headquarter Location)
  1.3.1 World GMP Cell Culture Custom Service Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company GMP Cell Culture Custom Service Revenue (2021-2032)
  1.3.3 China Based Company GMP Cell Culture Custom Service Revenue (2021-2032)
  1.3.4 Europe Based Company GMP Cell Culture Custom Service Revenue (2021-2032)
  1.3.5 Japan Based Company GMP Cell Culture Custom Service Revenue (2021-2032)
  1.3.6 South Korea Based Company GMP Cell Culture Custom Service Revenue (2021-2032)
  1.3.7 ASEAN Based Company GMP Cell Culture Custom Service Revenue (2021-2032)
  1.3.8 India Based Company GMP Cell Culture Custom Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 GMP Cell Culture Custom Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World GMP Cell Culture Custom Service Consumption Value (2021-2032)
2.2 World GMP Cell Culture Custom Service Consumption Value by Region
  2.2.1 World GMP Cell Culture Custom Service Consumption Value by Region (2021-2026)
  2.2.2 World GMP Cell Culture Custom Service Consumption Value Forecast by Region (2027-2032)
2.3 United States GMP Cell Culture Custom Service Consumption Value (2021-2032)
2.4 China GMP Cell Culture Custom Service Consumption Value (2021-2032)
2.5 Europe GMP Cell Culture Custom Service Consumption Value (2021-2032)
2.6 Japan GMP Cell Culture Custom Service Consumption Value (2021-2032)
2.7 South Korea GMP Cell Culture Custom Service Consumption Value (2021-2032)
2.8 ASEAN GMP Cell Culture Custom Service Consumption Value (2021-2032)
2.9 India GMP Cell Culture Custom Service Consumption Value (2021-2032)

3 WORLD GMP CELL CULTURE CUSTOM SERVICE COMPANIES COMPETITIVE ANALYSIS

3.1 World GMP Cell Culture Custom Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global GMP Cell Culture Custom Service Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for GMP Cell Culture Custom Service in 2025
  3.2.3 Global Concentration Ratios (CR8) for GMP Cell Culture Custom Service in 2025
3.3 GMP Cell Culture Custom Service Company Evaluation Quadrant
3.4 GMP Cell Culture Custom Service Market: Overall Company Footprint Analysis
  3.4.1 GMP Cell Culture Custom Service Market: Region Footprint
  3.4.2 GMP Cell Culture Custom Service Market: Company Product Type Footprint
  3.4.3 GMP Cell Culture Custom Service Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: GMP Cell Culture Custom Service Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: GMP Cell Culture Custom Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: GMP Cell Culture Custom Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: GMP Cell Culture Custom Service Consumption Value Comparison
  4.2.1 United States VS China: GMP Cell Culture Custom Service Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: GMP Cell Culture Custom Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based GMP Cell Culture Custom Service Companies and Market Share, 2021-2026
  4.3.1 United States Based GMP Cell Culture Custom Service Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies GMP Cell Culture Custom Service Revenue, (2021-2026)
4.4 China Based Companies GMP Cell Culture Custom Service Revenue and Market Share, 2021-2026
  4.4.1 China Based GMP Cell Culture Custom Service Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies GMP Cell Culture Custom Service Revenue, (2021-2026)
4.5 Rest of World Based GMP Cell Culture Custom Service Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based GMP Cell Culture Custom Service Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies GMP Cell Culture Custom Service Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World GMP Cell Culture Custom Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Mammalian Cells
  5.2.2 Immune Cells
5.3 Market Segment by Type
  5.3.1 World GMP Cell Culture Custom Service Market Size by Type (2021-2026)
  5.3.2 World GMP Cell Culture Custom Service Market Size by Type (2027-2032)
  5.3.3 World GMP Cell Culture Custom Service Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY BATCH CULTURE SCALE

6.1 World GMP Cell Culture Custom Service Market Size Overview by Batch Culture Scale: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Batch Culture Scale
  6.2.1 ≤10L
  6.2.2 ≥10L
6.3 Market Segment by Batch Culture Scale
  6.3.1 World GMP Cell Culture Custom Service Market Size by Batch Culture Scale (2021-2026)
  6.3.2 World GMP Cell Culture Custom Service Market Size by Batch Culture Scale (2027-2032)
  6.3.3 World GMP Cell Culture Custom Service Market Size Market Share by Batch Culture Scale (2027-2032)

7 MARKET ANALYSIS BY CULTURE SYSTEM

7.1 World GMP Cell Culture Custom Service Market Size Overview by Culture System: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Culture System
  7.2.1 Adherent Cells
  7.2.2 Suspension Cells
7.3 Market Segment by Culture System
  7.3.1 World GMP Cell Culture Custom Service Market Size by Culture System (2021-2026)
  7.3.2 World GMP Cell Culture Custom Service Market Size by Culture System (2027-2032)
  7.3.3 World GMP Cell Culture Custom Service Market Size Market Share by Culture System (2027-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World GMP Cell Culture Custom Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Gene Therapy
  8.2.2 Biopharmaceuticals
  8.2.3 Vaccine R&D and Production
  8.2.4 Other
8.3 Market Segment by Application
  8.3.1 World GMP Cell Culture Custom Service Market Size by Application (2021-2026)
  8.3.2 World GMP Cell Culture Custom Service Market Size by Application (2027-2032)
  8.3.3 World GMP Cell Culture Custom Service Market Size Market Share by Application (2021-2032)

9 COMPANY PROFILES

9.1 Samsung Biologics Co., Ltd.
  9.1.1 Samsung Biologics Co., Ltd. Details
  9.1.2 Samsung Biologics Co., Ltd. Major Business
  9.1.3 Samsung Biologics Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.1.4 Samsung Biologics Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.1.5 Samsung Biologics Co., Ltd. Recent Developments/Updates
  9.1.6 Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
9.2 WuXi Biologics (Cayman) Inc.
  9.2.1 WuXi Biologics (Cayman) Inc. Details
  9.2.2 WuXi Biologics (Cayman) Inc. Major Business
  9.2.3 WuXi Biologics (Cayman) Inc. GMP Cell Culture Custom Service Product and Services
  9.2.4 WuXi Biologics (Cayman) Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.2.5 WuXi Biologics (Cayman) Inc. Recent Developments/Updates
  9.2.6 WuXi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
9.3 Lonza Group Ltd
  9.3.1 Lonza Group Ltd Details
  9.3.2 Lonza Group Ltd Major Business
  9.3.3 Lonza Group Ltd GMP Cell Culture Custom Service Product and Services
  9.3.4 Lonza Group Ltd GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.3.5 Lonza Group Ltd Recent Developments/Updates
  9.3.6 Lonza Group Ltd Competitive Strengths & Weaknesses
9.4 Thermo Fisher Scientific Inc. (Patheon)
  9.4.1 Thermo Fisher Scientific Inc. (Patheon) Details
  9.4.2 Thermo Fisher Scientific Inc. (Patheon) Major Business
  9.4.3 Thermo Fisher Scientific Inc. (Patheon) GMP Cell Culture Custom Service Product and Services
  9.4.4 Thermo Fisher Scientific Inc. (Patheon) GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.4.5 Thermo Fisher Scientific Inc. (Patheon) Recent Developments/Updates
  9.4.6 Thermo Fisher Scientific Inc. (Patheon) Competitive Strengths & Weaknesses
9.5 FUJIFILM Holdings Corporation
  9.5.1 FUJIFILM Holdings Corporation Details
  9.5.2 FUJIFILM Holdings Corporation Major Business
  9.5.3 FUJIFILM Holdings Corporation GMP Cell Culture Custom Service Product and Services
  9.5.4 FUJIFILM Holdings Corporation GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.5.5 FUJIFILM Holdings Corporation Recent Developments/Updates
  9.5.6 FUJIFILM Holdings Corporation Competitive Strengths & Weaknesses
9.6 Boehringer Ingelheim
  9.6.1 Boehringer Ingelheim Details
  9.6.2 Boehringer Ingelheim Major Business
  9.6.3 Boehringer Ingelheim GMP Cell Culture Custom Service Product and Services
  9.6.4 Boehringer Ingelheim GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.6.5 Boehringer Ingelheim Recent Developments/Updates
  9.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
9.7 AGC Inc.
  9.7.1 AGC Inc. Details
  9.7.2 AGC Inc. Major Business
  9.7.3 AGC Inc. GMP Cell Culture Custom Service Product and Services
  9.7.4 AGC Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.7.5 AGC Inc. Recent Developments/Updates
  9.7.6 AGC Inc. Competitive Strengths & Weaknesses
9.8 Catalent, Inc.
  9.8.1 Catalent, Inc. Details
  9.8.2 Catalent, Inc. Major Business
  9.8.3 Catalent, Inc. GMP Cell Culture Custom Service Product and Services
  9.8.4 Catalent, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.8.5 Catalent, Inc. Recent Developments/Updates
  9.8.6 Catalent, Inc. Competitive Strengths & Weaknesses
9.9 KBI Biopharma, Inc.
  9.9.1 KBI Biopharma, Inc. Details
  9.9.2 KBI Biopharma, Inc. Major Business
  9.9.3 KBI Biopharma, Inc. GMP Cell Culture Custom Service Product and Services
  9.9.4 KBI Biopharma, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.9.5 KBI Biopharma, Inc. Recent Developments/Updates
  9.9.6 KBI Biopharma, Inc. Competitive Strengths & Weaknesses
9.10 Rentschler Biopharma SE
  9.10.1 Rentschler Biopharma SE Details
  9.10.2 Rentschler Biopharma SE Major Business
  9.10.3 Rentschler Biopharma SE GMP Cell Culture Custom Service Product and Services
  9.10.4 Rentschler Biopharma SE GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.10.5 Rentschler Biopharma SE Recent Developments/Updates
  9.10.6 Rentschler Biopharma SE Competitive Strengths & Weaknesses
9.11 Curia Global, Inc.
  9.11.1 Curia Global, Inc. Details
  9.11.2 Curia Global, Inc. Major Business
  9.11.3 Curia Global, Inc. GMP Cell Culture Custom Service Product and Services
  9.11.4 Curia Global, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.11.5 Curia Global, Inc. Recent Developments/Updates
  9.11.6 Curia Global, Inc. Competitive Strengths & Weaknesses
9.12 Avid Bioservices, Inc.
  9.12.1 Avid Bioservices, Inc. Details
  9.12.2 Avid Bioservices, Inc. Major Business
  9.12.3 Avid Bioservices, Inc. GMP Cell Culture Custom Service Product and Services
  9.12.4 Avid Bioservices, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.12.5 Avid Bioservices, Inc. Recent Developments/Updates
  9.12.6 Avid Bioservices, Inc. Competitive Strengths & Weaknesses
9.13 National Resilience, Inc.
  9.13.1 National Resilience, Inc. Details
  9.13.2 National Resilience, Inc. Major Business
  9.13.3 National Resilience, Inc. GMP Cell Culture Custom Service Product and Services
  9.13.4 National Resilience, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.13.5 National Resilience, Inc. Recent Developments/Updates
  9.13.6 National Resilience, Inc. Competitive Strengths & Weaknesses
9.14 Abzena plc
  9.14.1 Abzena plc Details
  9.14.2 Abzena plc Major Business
  9.14.3 Abzena plc GMP Cell Culture Custom Service Product and Services
  9.14.4 Abzena plc GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.14.5 Abzena plc Recent Developments/Updates
  9.14.6 Abzena plc Competitive Strengths & Weaknesses
9.15 LOTTE Biologics Co., Ltd.
  9.15.1 LOTTE Biologics Co., Ltd. Details
  9.15.2 LOTTE Biologics Co., Ltd. Major Business
  9.15.3 LOTTE Biologics Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.15.4 LOTTE Biologics Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.15.5 LOTTE Biologics Co., Ltd. Recent Developments/Updates
  9.15.6 LOTTE Biologics Co., Ltd. Competitive Strengths & Weaknesses
9.16 Cytovance Biologics, Inc.
  9.16.1 Cytovance Biologics, Inc. Details
  9.16.2 Cytovance Biologics, Inc. Major Business
  9.16.3 Cytovance Biologics, Inc. GMP Cell Culture Custom Service Product and Services
  9.16.4 Cytovance Biologics, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.16.5 Cytovance Biologics, Inc. Recent Developments/Updates
  9.16.6 Cytovance Biologics, Inc. Competitive Strengths & Weaknesses
9.17 BiBo Biopharma Engineering Co., Ltd.
  9.17.1 BiBo Biopharma Engineering Co., Ltd. Details
  9.17.2 BiBo Biopharma Engineering Co., Ltd. Major Business
  9.17.3 BiBo Biopharma Engineering Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.17.4 BiBo Biopharma Engineering Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.17.5 BiBo Biopharma Engineering Co., Ltd. Recent Developments/Updates
  9.17.6 BiBo Biopharma Engineering Co., Ltd. Competitive Strengths & Weaknesses
9.18 Chime Biologics (Wuhan) Co., Ltd.
  9.18.1 Chime Biologics (Wuhan) Co., Ltd. Details
  9.18.2 Chime Biologics (Wuhan) Co., Ltd. Major Business
  9.18.3 Chime Biologics (Wuhan) Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.18.4 Chime Biologics (Wuhan) Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.18.5 Chime Biologics (Wuhan) Co., Ltd. Recent Developments/Updates
  9.18.6 Chime Biologics (Wuhan) Co., Ltd. Competitive Strengths & Weaknesses
9.19 Celonic AG
  9.19.1 Celonic AG Details
  9.19.2 Celonic AG Major Business
  9.19.3 Celonic AG GMP Cell Culture Custom Service Product and Services
  9.19.4 Celonic AG GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.19.5 Celonic AG Recent Developments/Updates
  9.19.6 Celonic AG Competitive Strengths & Weaknesses
9.20 mAbxience
  9.20.1 mAbxience Details
  9.20.2 mAbxience Major Business
  9.20.3 mAbxience GMP Cell Culture Custom Service Product and Services
  9.20.4 mAbxience GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.20.5 mAbxience Recent Developments/Updates
  9.20.6 mAbxience Competitive Strengths & Weaknesses
9.21 Pharmaron Beijing Co., Ltd.
  9.21.1 Pharmaron Beijing Co., Ltd. Details
  9.21.2 Pharmaron Beijing Co., Ltd. Major Business
  9.21.3 Pharmaron Beijing Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.21.4 Pharmaron Beijing Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.21.5 Pharmaron Beijing Co., Ltd. Recent Developments/Updates
  9.21.6 Pharmaron Beijing Co., Ltd. Competitive Strengths & Weaknesses
9.22 GenScript Biotech Corporation (ProBio)
  9.22.1 GenScript Biotech Corporation (ProBio) Details
  9.22.2 GenScript Biotech Corporation (ProBio) Major Business
  9.22.3 GenScript Biotech Corporation (ProBio) GMP Cell Culture Custom Service Product and Services
  9.22.4 GenScript Biotech Corporation (ProBio) GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.22.5 GenScript Biotech Corporation (ProBio) Recent Developments/Updates
  9.22.6 GenScript Biotech Corporation (ProBio) Competitive Strengths & Weaknesses
9.23 GC Cell Corporation
  9.23.1 GC Cell Corporation Details
  9.23.2 GC Cell Corporation Major Business
  9.23.3 GC Cell Corporation GMP Cell Culture Custom Service Product and Services
  9.23.4 GC Cell Corporation GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.23.5 GC Cell Corporation Recent Developments/Updates
  9.23.6 GC Cell Corporation Competitive Strengths & Weaknesses
9.24 SK pharmteco
  9.24.1 SK pharmteco Details
  9.24.2 SK pharmteco Major Business
  9.24.3 SK pharmteco GMP Cell Culture Custom Service Product and Services
  9.24.4 SK pharmteco GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.24.5 SK pharmteco Recent Developments/Updates
  9.24.6 SK pharmteco Competitive Strengths & Weaknesses
9.25 Charles River Laboratories International, Inc.
  9.25.1 Charles River Laboratories International, Inc. Details
  9.25.2 Charles River Laboratories International, Inc. Major Business
  9.25.3 Charles River Laboratories International, Inc. GMP Cell Culture Custom Service Product and Services
  9.25.4 Charles River Laboratories International, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.25.5 Charles River Laboratories International, Inc. Recent Developments/Updates
  9.25.6 Charles River Laboratories International, Inc. Competitive Strengths & Weaknesses
9.26 Syngene International Limited
  9.26.1 Syngene International Limited Details
  9.26.2 Syngene International Limited Major Business
  9.26.3 Syngene International Limited GMP Cell Culture Custom Service Product and Services
  9.26.4 Syngene International Limited GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.26.5 Syngene International Limited Recent Developments/Updates
  9.26.6 Syngene International Limited Competitive Strengths & Weaknesses
9.27 Prestige Biologics Co., Ltd.
  9.27.1 Prestige Biologics Co., Ltd. Details
  9.27.2 Prestige Biologics Co., Ltd. Major Business
  9.27.3 Prestige Biologics Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.27.4 Prestige Biologics Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.27.5 Prestige Biologics Co., Ltd. Recent Developments/Updates
  9.27.6 Prestige Biologics Co., Ltd. Competitive Strengths & Weaknesses
9.28 EirGenix, Inc.
  9.28.1 EirGenix, Inc. Details
  9.28.2 EirGenix, Inc. Major Business
  9.28.3 EirGenix, Inc. GMP Cell Culture Custom Service Product and Services
  9.28.4 EirGenix, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.28.5 EirGenix, Inc. Recent Developments/Updates
  9.28.6 EirGenix, Inc. Competitive Strengths & Weaknesses
9.29 Shanghai ZhenGe Biotech Co., Ltd.
  9.29.1 Shanghai ZhenGe Biotech Co., Ltd. Details
  9.29.2 Shanghai ZhenGe Biotech Co., Ltd. Major Business
  9.29.3 Shanghai ZhenGe Biotech Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.29.4 Shanghai ZhenGe Biotech Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.29.5 Shanghai ZhenGe Biotech Co., Ltd. Recent Developments/Updates
  9.29.6 Shanghai ZhenGe Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.30 Mycenax Biotech Inc.
  9.30.1 Mycenax Biotech Inc. Details
  9.30.2 Mycenax Biotech Inc. Major Business
  9.30.3 Mycenax Biotech Inc. GMP Cell Culture Custom Service Product and Services
  9.30.4 Mycenax Biotech Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.30.5 Mycenax Biotech Inc. Recent Developments/Updates
  9.30.6 Mycenax Biotech Inc. Competitive Strengths & Weaknesses
9.31 Bora Pharmaceuticals Co., Ltd. (Bora Biologics)
  9.31.1 Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Details
  9.31.2 Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Major Business
  9.31.3 Bora Pharmaceuticals Co., Ltd. (Bora Biologics) GMP Cell Culture Custom Service Product and Services
  9.31.4 Bora Pharmaceuticals Co., Ltd. (Bora Biologics) GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.31.5 Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Recent Developments/Updates
  9.31.6 Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Competitive Strengths & Weaknesses
9.32 ProBioGen AG
  9.32.1 ProBioGen AG Details
  9.32.2 ProBioGen AG Major Business
  9.32.3 ProBioGen AG GMP Cell Culture Custom Service Product and Services
  9.32.4 ProBioGen AG GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.32.5 ProBioGen AG Recent Developments/Updates
  9.32.6 ProBioGen AG Competitive Strengths & Weaknesses
9.33 OBiO Technology (Shanghai) Corp., Ltd.
  9.33.1 OBiO Technology (Shanghai) Corp., Ltd. Details
  9.33.2 OBiO Technology (Shanghai) Corp., Ltd. Major Business
  9.33.3 OBiO Technology (Shanghai) Corp., Ltd. GMP Cell Culture Custom Service Product and Services
  9.33.4 OBiO Technology (Shanghai) Corp., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.33.5 OBiO Technology (Shanghai) Corp., Ltd. Recent Developments/Updates
  9.33.6 OBiO Technology (Shanghai) Corp., Ltd. Competitive Strengths & Weaknesses
9.34 Enzene Biosciences Ltd.
  9.34.1 Enzene Biosciences Ltd. Details
  9.34.2 Enzene Biosciences Ltd. Major Business
  9.34.3 Enzene Biosciences Ltd. GMP Cell Culture Custom Service Product and Services
  9.34.4 Enzene Biosciences Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.34.5 Enzene Biosciences Ltd. Recent Developments/Updates
  9.34.6 Enzene Biosciences Ltd. Competitive Strengths & Weaknesses
9.35 MabPlex International Co., Ltd.
  9.35.1 MabPlex International Co., Ltd. Details
  9.35.2 MabPlex International Co., Ltd. Major Business
  9.35.3 MabPlex International Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.35.4 MabPlex International Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.35.5 MabPlex International Co., Ltd. Recent Developments/Updates
  9.35.6 MabPlex International Co., Ltd. Competitive Strengths & Weaknesses
9.36 Hualan Ankang Shengwu Gufen Youxian Gongsi
  9.36.1 Hualan Ankang Shengwu Gufen Youxian Gongsi Details
  9.36.2 Hualan Ankang Shengwu Gufen Youxian Gongsi Major Business
  9.36.3 Hualan Ankang Shengwu Gufen Youxian Gongsi GMP Cell Culture Custom Service Product and Services
  9.36.4 Hualan Ankang Shengwu Gufen Youxian Gongsi GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.36.5 Hualan Ankang Shengwu Gufen Youxian Gongsi Recent Developments/Updates
  9.36.6 Hualan Ankang Shengwu Gufen Youxian Gongsi Competitive Strengths & Weaknesses
9.37 CHA Biotech Co., Ltd.
  9.37.1 CHA Biotech Co., Ltd. Details
  9.37.2 CHA Biotech Co., Ltd. Major Business
  9.37.3 CHA Biotech Co., Ltd. GMP Cell Culture Custom Service Product and Services
  9.37.4 CHA Biotech Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.37.5 CHA Biotech Co., Ltd. Recent Developments/Updates
  9.37.6 CHA Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.38 VIVEbiotech S.L.
  9.38.1 VIVEbiotech S.L. Details
  9.38.2 VIVEbiotech S.L. Major Business
  9.38.3 VIVEbiotech S.L. GMP Cell Culture Custom Service Product and Services
  9.38.4 VIVEbiotech S.L. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.38.5 VIVEbiotech S.L. Recent Developments/Updates
  9.38.6 VIVEbiotech S.L. Competitive Strengths & Weaknesses
9.39 UNIGEN Inc.
  9.39.1 UNIGEN Inc. Details
  9.39.2 UNIGEN Inc. Major Business
  9.39.3 UNIGEN Inc. GMP Cell Culture Custom Service Product and Services
  9.39.4 UNIGEN Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.39.5 UNIGEN Inc. Recent Developments/Updates
  9.39.6 UNIGEN Inc. Competitive Strengths & Weaknesses
9.40 Takara Bio Inc.
  9.40.1 Takara Bio Inc. Details
  9.40.2 Takara Bio Inc. Major Business
  9.40.3 Takara Bio Inc. GMP Cell Culture Custom Service Product and Services
  9.40.4 Takara Bio Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026)
  9.40.5 Takara Bio Inc. Recent Developments/Updates
  9.40.6 Takara Bio Inc. Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 GMP Cell Culture Custom Service Industry Chain
10.2 GMP Cell Culture Custom Service Upstream Analysis
10.3 GMP Cell Culture Custom Service Midstream Analysis
10.4 GMP Cell Culture Custom Service Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES

Table 1. World GMP Cell Culture Custom Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World GMP Cell Culture Custom Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World GMP Cell Culture Custom Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World GMP Cell Culture Custom Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World GMP Cell Culture Custom Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GMP Cell Culture Custom Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World GMP Cell Culture Custom Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World GMP Cell Culture Custom Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World GMP Cell Culture Custom Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key GMP Cell Culture Custom Service Players in 2025
Table 12. World GMP Cell Culture Custom Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global GMP Cell Culture Custom Service Company Evaluation Quadrant
Table 14. Head Office of Key GMP Cell Culture Custom Service Players
Table 15. GMP Cell Culture Custom Service Market: Company Product Type Footprint
Table 16. GMP Cell Culture Custom Service Market: Company Product Application Footprint
Table 17. GMP Cell Culture Custom Service Mergers & Acquisitions Activity
Table 18. United States VS China GMP Cell Culture Custom Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China GMP Cell Culture Custom Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based GMP Cell Culture Custom Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies GMP Cell Culture Custom Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies GMP Cell Culture Custom Service Revenue Market Share (2021-2026)
Table 23. China Based GMP Cell Culture Custom Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies GMP Cell Culture Custom Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies GMP Cell Culture Custom Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based GMP Cell Culture Custom Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies GMP Cell Culture Custom Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies GMP Cell Culture Custom Service Revenue Market Share (2021-2026)
Table 29. World GMP Cell Culture Custom Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World GMP Cell Culture Custom Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World GMP Cell Culture Custom Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World GMP Cell Culture Custom Service Market Size by Batch Culture Scale, (USD Million), 2021 & 2025 & 2032
Table 33. World GMP Cell Culture Custom Service Market Size Value by Batch Culture Scale (2021-2026) & (USD Million)
Table 34. World GMP Cell Culture Custom Service Market Size by Batch Culture Scale (2027-2032) & (USD Million)
Table 35. World GMP Cell Culture Custom Service Market Size by Culture System, (USD Million), 2021 & 2025 & 2032
Table 36. World GMP Cell Culture Custom Service Market Size Value by Culture System (2021-2026) & (USD Million)
Table 37. World GMP Cell Culture Custom Service Market Size by Culture System (2027-2032) & (USD Million)
Table 38. World GMP Cell Culture Custom Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World GMP Cell Culture Custom Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World GMP Cell Culture Custom Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Samsung Biologics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 42. Samsung Biologics Co., Ltd. Major Business
Table 43. Samsung Biologics Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 44. Samsung Biologics Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Samsung Biologics Co., Ltd. Recent Developments/Updates
Table 46. Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
Table 47. WuXi Biologics (Cayman) Inc. Basic Information, Manufacturing Base and Competitors
Table 48. WuXi Biologics (Cayman) Inc. Major Business
Table 49. WuXi Biologics (Cayman) Inc. GMP Cell Culture Custom Service Product and Services
Table 50. WuXi Biologics (Cayman) Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. WuXi Biologics (Cayman) Inc. Recent Developments/Updates
Table 52. WuXi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
Table 53. Lonza Group Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Lonza Group Ltd Major Business
Table 55. Lonza Group Ltd GMP Cell Culture Custom Service Product and Services
Table 56. Lonza Group Ltd GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Lonza Group Ltd Recent Developments/Updates
Table 58. Lonza Group Ltd Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Scientific Inc. (Patheon) Basic Information, Manufacturing Base and Competitors
Table 60. Thermo Fisher Scientific Inc. (Patheon) Major Business
Table 61. Thermo Fisher Scientific Inc. (Patheon) GMP Cell Culture Custom Service Product and Services
Table 62. Thermo Fisher Scientific Inc. (Patheon) GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Thermo Fisher Scientific Inc. (Patheon) Recent Developments/Updates
Table 64. Thermo Fisher Scientific Inc. (Patheon) Competitive Strengths & Weaknesses
Table 65. FUJIFILM Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 66. FUJIFILM Holdings Corporation Major Business
Table 67. FUJIFILM Holdings Corporation GMP Cell Culture Custom Service Product and Services
Table 68. FUJIFILM Holdings Corporation GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. FUJIFILM Holdings Corporation Recent Developments/Updates
Table 70. FUJIFILM Holdings Corporation Competitive Strengths & Weaknesses
Table 71. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 72. Boehringer Ingelheim Major Business
Table 73. Boehringer Ingelheim GMP Cell Culture Custom Service Product and Services
Table 74. Boehringer Ingelheim GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Boehringer Ingelheim Recent Developments/Updates
Table 76. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 77. AGC Inc. Basic Information, Manufacturing Base and Competitors
Table 78. AGC Inc. Major Business
Table 79. AGC Inc. GMP Cell Culture Custom Service Product and Services
Table 80. AGC Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. AGC Inc. Recent Developments/Updates
Table 82. AGC Inc. Competitive Strengths & Weaknesses
Table 83. Catalent, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Catalent, Inc. Major Business
Table 85. Catalent, Inc. GMP Cell Culture Custom Service Product and Services
Table 86. Catalent, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Catalent, Inc. Recent Developments/Updates
Table 88. Catalent, Inc. Competitive Strengths & Weaknesses
Table 89. KBI Biopharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 90. KBI Biopharma, Inc. Major Business
Table 91. KBI Biopharma, Inc. GMP Cell Culture Custom Service Product and Services
Table 92. KBI Biopharma, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. KBI Biopharma, Inc. Recent Developments/Updates
Table 94. KBI Biopharma, Inc. Competitive Strengths & Weaknesses
Table 95. Rentschler Biopharma SE Basic Information, Manufacturing Base and Competitors
Table 96. Rentschler Biopharma SE Major Business
Table 97. Rentschler Biopharma SE GMP Cell Culture Custom Service Product and Services
Table 98. Rentschler Biopharma SE GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Rentschler Biopharma SE Recent Developments/Updates
Table 100. Rentschler Biopharma SE Competitive Strengths & Weaknesses
Table 101. Curia Global, Inc. Basic Information, Manufacturing Base and Competitors
Table 102. Curia Global, Inc. Major Business
Table 103. Curia Global, Inc. GMP Cell Culture Custom Service Product and Services
Table 104. Curia Global, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Curia Global, Inc. Recent Developments/Updates
Table 106. Curia Global, Inc. Competitive Strengths & Weaknesses
Table 107. Avid Bioservices, Inc. Basic Information, Manufacturing Base and Competitors
Table 108. Avid Bioservices, Inc. Major Business
Table 109. Avid Bioservices, Inc. GMP Cell Culture Custom Service Product and Services
Table 110. Avid Bioservices, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Avid Bioservices, Inc. Recent Developments/Updates
Table 112. Avid Bioservices, Inc. Competitive Strengths & Weaknesses
Table 113. National Resilience, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. National Resilience, Inc. Major Business
Table 115. National Resilience, Inc. GMP Cell Culture Custom Service Product and Services
Table 116. National Resilience, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. National Resilience, Inc. Recent Developments/Updates
Table 118. National Resilience, Inc. Competitive Strengths & Weaknesses
Table 119. Abzena plc Basic Information, Manufacturing Base and Competitors
Table 120. Abzena plc Major Business
Table 121. Abzena plc GMP Cell Culture Custom Service Product and Services
Table 122. Abzena plc GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Abzena plc Recent Developments/Updates
Table 124. Abzena plc Competitive Strengths & Weaknesses
Table 125. LOTTE Biologics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 126. LOTTE Biologics Co., Ltd. Major Business
Table 127. LOTTE Biologics Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 128. LOTTE Biologics Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. LOTTE Biologics Co., Ltd. Recent Developments/Updates
Table 130. LOTTE Biologics Co., Ltd. Competitive Strengths & Weaknesses
Table 131. Cytovance Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 132. Cytovance Biologics, Inc. Major Business
Table 133. Cytovance Biologics, Inc. GMP Cell Culture Custom Service Product and Services
Table 134. Cytovance Biologics, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Cytovance Biologics, Inc. Recent Developments/Updates
Table 136. Cytovance Biologics, Inc. Competitive Strengths & Weaknesses
Table 137. BiBo Biopharma Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 138. BiBo Biopharma Engineering Co., Ltd. Major Business
Table 139. BiBo Biopharma Engineering Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 140. BiBo Biopharma Engineering Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. BiBo Biopharma Engineering Co., Ltd. Recent Developments/Updates
Table 142. BiBo Biopharma Engineering Co., Ltd. Competitive Strengths & Weaknesses
Table 143. Chime Biologics (Wuhan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. Chime Biologics (Wuhan) Co., Ltd. Major Business
Table 145. Chime Biologics (Wuhan) Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 146. Chime Biologics (Wuhan) Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Chime Biologics (Wuhan) Co., Ltd. Recent Developments/Updates
Table 148. Chime Biologics (Wuhan) Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Celonic AG Basic Information, Manufacturing Base and Competitors
Table 150. Celonic AG Major Business
Table 151. Celonic AG GMP Cell Culture Custom Service Product and Services
Table 152. Celonic AG GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Celonic AG Recent Developments/Updates
Table 154. Celonic AG Competitive Strengths & Weaknesses
Table 155. mAbxience Basic Information, Manufacturing Base and Competitors
Table 156. mAbxience Major Business
Table 157. mAbxience GMP Cell Culture Custom Service Product and Services
Table 158. mAbxience GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. mAbxience Recent Developments/Updates
Table 160. mAbxience Competitive Strengths & Weaknesses
Table 161. Pharmaron Beijing Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 162. Pharmaron Beijing Co., Ltd. Major Business
Table 163. Pharmaron Beijing Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 164. Pharmaron Beijing Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Pharmaron Beijing Co., Ltd. Recent Developments/Updates
Table 166. Pharmaron Beijing Co., Ltd. Competitive Strengths & Weaknesses
Table 167. GenScript Biotech Corporation (ProBio) Basic Information, Manufacturing Base and Competitors
Table 168. GenScript Biotech Corporation (ProBio) Major Business
Table 169. GenScript Biotech Corporation (ProBio) GMP Cell Culture Custom Service Product and Services
Table 170. GenScript Biotech Corporation (ProBio) GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. GenScript Biotech Corporation (ProBio) Recent Developments/Updates
Table 172. GenScript Biotech Corporation (ProBio) Competitive Strengths & Weaknesses
Table 173. GC Cell Corporation Basic Information, Manufacturing Base and Competitors
Table 174. GC Cell Corporation Major Business
Table 175. GC Cell Corporation GMP Cell Culture Custom Service Product and Services
Table 176. GC Cell Corporation GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. GC Cell Corporation Recent Developments/Updates
Table 178. GC Cell Corporation Competitive Strengths & Weaknesses
Table 179. SK pharmteco Basic Information, Manufacturing Base and Competitors
Table 180. SK pharmteco Major Business
Table 181. SK pharmteco GMP Cell Culture Custom Service Product and Services
Table 182. SK pharmteco GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. SK pharmteco Recent Developments/Updates
Table 184. SK pharmteco Competitive Strengths & Weaknesses
Table 185. Charles River Laboratories International, Inc. Basic Information, Manufacturing Base and Competitors
Table 186. Charles River Laboratories International, Inc. Major Business
Table 187. Charles River Laboratories International, Inc. GMP Cell Culture Custom Service Product and Services
Table 188. Charles River Laboratories International, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Charles River Laboratories International, Inc. Recent Developments/Updates
Table 190. Charles River Laboratories International, Inc. Competitive Strengths & Weaknesses
Table 191. Syngene International Limited Basic Information, Manufacturing Base and Competitors
Table 192. Syngene International Limited Major Business
Table 193. Syngene International Limited GMP Cell Culture Custom Service Product and Services
Table 194. Syngene International Limited GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Syngene International Limited Recent Developments/Updates
Table 196. Syngene International Limited Competitive Strengths & Weaknesses
Table 197. Prestige Biologics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 198. Prestige Biologics Co., Ltd. Major Business
Table 199. Prestige Biologics Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 200. Prestige Biologics Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Prestige Biologics Co., Ltd. Recent Developments/Updates
Table 202. Prestige Biologics Co., Ltd. Competitive Strengths & Weaknesses
Table 203. EirGenix, Inc. Basic Information, Manufacturing Base and Competitors
Table 204. EirGenix, Inc. Major Business
Table 205. EirGenix, Inc. GMP Cell Culture Custom Service Product and Services
Table 206. EirGenix, Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. EirGenix, Inc. Recent Developments/Updates
Table 208. EirGenix, Inc. Competitive Strengths & Weaknesses
Table 209. Shanghai ZhenGe Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 210. Shanghai ZhenGe Biotech Co., Ltd. Major Business
Table 211. Shanghai ZhenGe Biotech Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 212. Shanghai ZhenGe Biotech Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Shanghai ZhenGe Biotech Co., Ltd. Recent Developments/Updates
Table 214. Shanghai ZhenGe Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 215. Mycenax Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 216. Mycenax Biotech Inc. Major Business
Table 217. Mycenax Biotech Inc. GMP Cell Culture Custom Service Product and Services
Table 218. Mycenax Biotech Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Mycenax Biotech Inc. Recent Developments/Updates
Table 220. Mycenax Biotech Inc. Competitive Strengths & Weaknesses
Table 221. Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Basic Information, Manufacturing Base and Competitors
Table 222. Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Major Business
Table 223. Bora Pharmaceuticals Co., Ltd. (Bora Biologics) GMP Cell Culture Custom Service Product and Services
Table 224. Bora Pharmaceuticals Co., Ltd. (Bora Biologics) GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Recent Developments/Updates
Table 226. Bora Pharmaceuticals Co., Ltd. (Bora Biologics) Competitive Strengths & Weaknesses
Table 227. ProBioGen AG Basic Information, Manufacturing Base and Competitors
Table 228. ProBioGen AG Major Business
Table 229. ProBioGen AG GMP Cell Culture Custom Service Product and Services
Table 230. ProBioGen AG GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. ProBioGen AG Recent Developments/Updates
Table 232. ProBioGen AG Competitive Strengths & Weaknesses
Table 233. OBiO Technology (Shanghai) Corp., Ltd. Basic Information, Manufacturing Base and Competitors
Table 234. OBiO Technology (Shanghai) Corp., Ltd. Major Business
Table 235. OBiO Technology (Shanghai) Corp., Ltd. GMP Cell Culture Custom Service Product and Services
Table 236. OBiO Technology (Shanghai) Corp., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. OBiO Technology (Shanghai) Corp., Ltd. Recent Developments/Updates
Table 238. OBiO Technology (Shanghai) Corp., Ltd. Competitive Strengths & Weaknesses
Table 239. Enzene Biosciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 240. Enzene Biosciences Ltd. Major Business
Table 241. Enzene Biosciences Ltd. GMP Cell Culture Custom Service Product and Services
Table 242. Enzene Biosciences Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Enzene Biosciences Ltd. Recent Developments/Updates
Table 244. Enzene Biosciences Ltd. Competitive Strengths & Weaknesses
Table 245. MabPlex International Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 246. MabPlex International Co., Ltd. Major Business
Table 247. MabPlex International Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 248. MabPlex International Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. MabPlex International Co., Ltd. Recent Developments/Updates
Table 250. MabPlex International Co., Ltd. Competitive Strengths & Weaknesses
Table 251. Hualan Ankang Shengwu Gufen Youxian Gongsi Basic Information, Manufacturing Base and Competitors
Table 252. Hualan Ankang Shengwu Gufen Youxian Gongsi Major Business
Table 253. Hualan Ankang Shengwu Gufen Youxian Gongsi GMP Cell Culture Custom Service Product and Services
Table 254. Hualan Ankang Shengwu Gufen Youxian Gongsi GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Hualan Ankang Shengwu Gufen Youxian Gongsi Recent Developments/Updates
Table 256. Hualan Ankang Shengwu Gufen Youxian Gongsi Competitive Strengths & Weaknesses
Table 257. CHA Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 258. CHA Biotech Co., Ltd. Major Business
Table 259. CHA Biotech Co., Ltd. GMP Cell Culture Custom Service Product and Services
Table 260. CHA Biotech Co., Ltd. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. CHA Biotech Co., Ltd. Recent Developments/Updates
Table 262. CHA Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 263. VIVEbiotech S.L. Basic Information, Manufacturing Base and Competitors
Table 264. VIVEbiotech S.L. Major Business
Table 265. VIVEbiotech S.L. GMP Cell Culture Custom Service Product and Services
Table 266. VIVEbiotech S.L. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. VIVEbiotech S.L. Recent Developments/Updates
Table 268. VIVEbiotech S.L. Competitive Strengths & Weaknesses
Table 269. UNIGEN Inc. Basic Information, Manufacturing Base and Competitors
Table 270. UNIGEN Inc. Major Business
Table 271. UNIGEN Inc. GMP Cell Culture Custom Service Product and Services
Table 272. UNIGEN Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. UNIGEN Inc. Recent Developments/Updates
Table 274. UNIGEN Inc. Competitive Strengths & Weaknesses
Table 275. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 276. Takara Bio Inc. Major Business
Table 277. Takara Bio Inc. GMP Cell Culture Custom Service Product and Services
Table 278. Takara Bio Inc. GMP Cell Culture Custom Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 279. Takara Bio Inc. Recent Developments/Updates
Table 280. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 281. Global Key Players of GMP Cell Culture Custom Service Upstream (Raw Materials)
Table 282. Global GMP Cell Culture Custom Service Typical Customers

LIST OF FIGURES

Figure 1. GMP Cell Culture Custom Service Picture
Figure 2. World GMP Cell Culture Custom Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GMP Cell Culture Custom Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World GMP Cell Culture Custom Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World GMP Cell Culture Custom Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company GMP Cell Culture Custom Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company GMP Cell Culture Custom Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company GMP Cell Culture Custom Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company GMP Cell Culture Custom Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company GMP Cell Culture Custom Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company GMP Cell Culture Custom Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company GMP Cell Culture Custom Service Revenue (2021-2032) & (USD Million)
Figure 13. GMP Cell Culture Custom Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World GMP Cell Culture Custom Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India GMP Cell Culture Custom Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of GMP Cell Culture Custom Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for GMP Cell Culture Custom Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for GMP Cell Culture Custom Service Markets in 2025
Figure 27. United States VS China: GMP Cell Culture Custom Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GMP Cell Culture Custom Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World GMP Cell Culture Custom Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World GMP Cell Culture Custom Service Market Size Market Share by Type in 2025
Figure 31. Mammalian Cells
Figure 32. Immune Cells
Figure 33. World GMP Cell Culture Custom Service Market Size Market Share by Type (2021-2032)
Figure 34. World GMP Cell Culture Custom Service Market Size by Batch Culture Scale, (USD Million), 2021 & 2025 & 2032
Figure 35. World GMP Cell Culture Custom Service Market Size Market Share by Batch Culture Scale in 2025
Figure 36. ≤10L
Figure 37. ≥10L
Figure 38. World GMP Cell Culture Custom Service Market Size Market Share by Batch Culture Scale (2021-2032)
Figure 39. World GMP Cell Culture Custom Service Market Size by Culture System, (USD Million), 2021 & 2025 & 2032
Figure 40. World GMP Cell Culture Custom Service Market Size Market Share by Culture System in 2025
Figure 41. Adherent Cells
Figure 42. Suspension Cells
Figure 43. World GMP Cell Culture Custom Service Market Size Market Share by Culture System (2021-2032)
Figure 44. World GMP Cell Culture Custom Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World GMP Cell Culture Custom Service Market Size Market Share by Application in 2025
Figure 46. Gene Therapy
Figure 47. Biopharmaceuticals
Figure 48. Vaccine R&D and Production
Figure 49. Other
Figure 50. World GMP Cell Culture Custom Service Market Size Market Share by Application (2021-2032)
Figure 51. GMP Cell Culture Custom Service Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source